Optogenetically Activatable MLKL as a Standalone Functional Module for Necroptosis and Therapeutic Applications in...

Area of Science:

• Cellular Biology
• Immunology
• Biotechnology

Background:

• Necroptosis is a regulated form of cell death implicated in disease progression and antitumor immunity.
• Complex upstream signaling pathways regulating necroptosis hinder therapeutic development.
• Precise control over necroptosis is needed to harness its immunomodulatory potential.

Purpose of the Study:

• To develop an optogenetically activatable necroptosis system for precise spatiotemporal control.
• To investigate the assembly and function of optogenetically controlled MLKL (optoMLKL).
• To evaluate the potential of optoMLKL in enhancing antitumor immunity and its therapeutic applications.

Main Methods:

• Development of an optogenetically activatable necroptosis system featuring optoMLKL.
• Investigation of optoMLKL assembly into higher-order structures.
• Assessment of innate immune responses triggered by optoMLKL activation, including damage-associated molecular patterns (DAMPs) release.
• Testing of optoMLKL in patient-derived pancreatic cancer organoids.

Main Results:

• OptoMLKL rapidly assembled into functional hotspots within cellular membranes, independent of RIPK3 phosphorylation.
• OptoMLKL activation significantly enhanced innate immune responses through the release of intracellular and cellular damage-associated molecular patterns (iDAMPs and cDAMPs).
• Activated optoMLKL demonstrated antitumor effects in pancreatic cancer organoids.

Conclusions:

• Optogenetic control of necroptosis provides a powerful tool to bypass complex signaling networks.
• OptoMLKL effectively enhances innate immune responses and exhibits direct antitumor activity.
• This optogenetic approach holds significant potential for developing novel cancer immunotherapies.